Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study: A Prospective, Interventional, Randomized Study of Community-based PrEP Initiation, Delivery, and Monitoring in South Africa

NCT06176859 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06176859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06176859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study: A Prospective, Interventional, Randomized Study of Community-based PrEP Initiation, Delivery, and Monitoring in South Africa
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 17, 2023
Completion date
March 26, 2026
Enrollment
2,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

art, hiv, human immunodeficiency virus